IOVA Iovance Biotherapeutics, Inc.
IOVA Iovance Biotherapeutics, Inc.
Healthcare · Biotechnology
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 bull converging
POC $3.73 · VWAP $4.93 · +176.5% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
IOVA Price Structure
Loading timeframes…
Peers
Every watchlist IOVA belongs to, members best 30-day change first — IOVA highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Against street estimates
How IOVA's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about IOVA from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 17 days ago · Sep 30
- Iovance Biotherapeutics (IOVA) Shares Surge Over 30% After Raising 2026 Revenue Forecast
- Why Is Iovance Biotherapeutics Stock Surging Today? - Iovance Biotherapeutics (NASDAQ:IOVA) - Benzinga
- Iovance Biotherapeutics, Inc. (IOVA) Stock Price, News, Quote & History - Yahoo Finance
- Iovance Biotherapeutics Earnings Q3 2026 | IOVA News & Analysis
- Iovance Biotherapeutics Raises Full Year 2026 Revenue Guidance to $410 to $420 Million - BioSpace
IOVA research tape
73 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.